Supplementary Figure from Resistance to ATR Inhibitors Is Mediated by Loss of the Nonsense-Mediated Decay Factor UPF2
Patrick C. O’Leary(University of California, San Francisco), Alan Ashworth(University of California, San Francisco), Morgan E. Diolaiti(University of California, San Francisco), Jonathan Chou(UCSF Helen Diller Family Comprehensive Cancer Center), Felix Y. Feng(University of Michigan), Tess Williamson(UCSF Helen Diller Family Comprehensive Cancer Center), Nevan J. Krogan(QB3), Julia Carnevale(Gladstone Institutes), Yagmur U. Doruk(UCSF Helen Diller Family Comprehensive Cancer Center), David A. Quigley(Universidad Católica de Santa Fe), Tanushree Shenoy, Andrew S. McNeal(UCSF Helen Diller Family Comprehensive Cancer Center), Erica Stevenson(QB3), Benjamin J. Polacco(QB3), Minkyu Kim(Korea Exercise Rehabilitation Association), Nupura Kale(University of California, San Francisco), Danielle L. Swaney(Gladstone Institutes), Huadong Chen(University of California, San Francisco)
Cited by 0
Related Papers
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
The Global Phosphorylation Landscape of SARS-CoV-2 Infection
|Cell|2020|1.2k
How many human proteoforms are there?
|Nature Chemical Biology|2018|945